CAS: 1337531-06-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK2593074A REF: 54-BUP05275CAS: 1337531-06-2 | ≥98% | 1.063,00 €~1.839,00 € | Vie 09 May 25 |
 | GSK2593074A REF: 3D-MDC53106CAS: 1337531-06-2 | Min. 95% | A consultar | Vie 20 Jun 25 |
 | GSK2593074A REF: TM-T11484CAS: 1337531-06-2 | 100% | 114,00 €~1.359,00 € | Jue 26 Jun 25 |
Ref: 54-BUP05275
| 25mg | 1.063,00 € | ||
| 50mg | 1.377,00 € | ||
| 100mg | 1.839,00 € |
Entrega estimada en Estados Unidos, el Viernes 9 de Mayo de 2025
GSK2593074A
CAS:1337531-06-2
Please enquire for more information about GSK2593074A including the price, delivery time and more detailed …
Fórmula:
C27H23N5OS
Pureza:
Min. 95%
Peso molecular:
465.57 g/mol
Ref: 3D-MDC53106
| 25mg | 1.242,00 € | ||
| 50mg | 1.727,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Junio de 2025
GSK2593074A
CAS:1337531-06-2
GSK2593074A (GSK'074) is a programmed necrosis inhibitor that displays inhibitory effects on RIP1 and RIP3.
Fórmula:
C27H23N5OS
Pureza:
100%
Forma y color:
Solid
Peso molecular:
465.57
Ref: TM-T11484
| 1mg | 114,00 € | ||
| 5mg | 274,00 € | ||
| 10mg | 432,00 € | ||
| 25mg | 725,00 € | ||
| 50mg | 1.017,00 € | ||
| 100mg | 1.359,00 € | ||
| 1mL*10mM (DMSO) | 303,00 € |
Entrega estimada en Estados Unidos, el Jueves 26 de Junio de 2025
